Adam Cartwright
About Adam Cartwright
Adam Cartwright is a Senior Scientist at Evelo Biosciences, where he specializes in designing and optimizing studies for monoclonal microbial therapies. He has a background in immunology and molecular medicine, with previous experience at institutions like GlaxoSmithKline and Dana-Farber Cancer Institute.
Current Role at Evelo Biosciences
Adam Cartwright serves as a Senior Scientist at Evelo Biosciences, a position he has held since 2021. In this role, he designs and optimizes in vivo and ex vivo studies aimed at screening and discovering monoclonal microbial therapies. He employs advanced techniques such as multi-parameter flow cytometry and cell sorting for immunological analysis. Additionally, he conducts pre-clinical studies for candidate selection and manages contract research organizations (CROs) to facilitate product development. His work also includes mechanistic analysis of monoclonal microbial therapies.
Previous Experience at Evelo Biosciences
Prior to his current position, Adam Cartwright worked as a Scientist at Evelo Biosciences from 2020 to 2021. During this year, he contributed to various research initiatives focused on microbial therapies. His experience at Evelo laid the groundwork for his advancement to Senior Scientist, where he continues to expand his research in this specialized field.
Postdoctoral Research at Dana-Farber Cancer Institute
Adam Cartwright was a Postdoctoral Research Fellow at Dana-Farber Cancer Institute from 2015 to 2020. His five-year tenure involved conducting advanced research in cancer biology, contributing to the institute's mission of improving cancer treatment and understanding. This experience enhanced his expertise in biomedical research and prepared him for subsequent roles in the industry.
Educational Background in Biomedical Sciences
Adam Cartwright's educational journey includes a Bachelor of Medical Science (B.Med.Sci) in Biomedical Materials Science from The University of Birmingham, completed from 2006 to 2009. He furthered his education at Imperial College London, where he earned a Master of Science (MSc) in Molecular Medicine in 2010 and a Doctor of Philosophy (PhD) in Immunology from 2010 to 2014. His academic background provides a strong foundation for his research and scientific endeavors.
Early Education and Academic Achievements
Adam Cartwright completed his early education at Chasetown High School, where he achieved GCSEs from 1999 to 2004. He then pursued A-Levels in Biology, Chemistry, Maths, and ICT from 2004 to 2006. This foundational education set the stage for his advanced studies in the sciences, leading to his subsequent degrees in biomedical fields.